Bartsch DU - Search Results

1

ANATOMICAL AND FUNCTIONAL TESTING IN DIABETIC PATIENTS WITHOUT RETINOPATHY: Results of Optical Coherence Tomography Angiography and Visual Acuity Under Varying Contrast and Luminance Conditions.

Meshi A, Chen KC, You QS, Dans K, Lin T, Bartsch DU, Cheng L, Amador-Patarroyo MJ, Muftuoglu IK, Gomez ML, Nudleman E, Freeman WR. Meshi A, et al. Among authors: bartsch du. Retina. 2019 Oct;39(10):2022-2031. doi: 10.1097/IAE.0000000000002258. Retina. 2019. PMID: 30015764 Free PMC article.

2

A false use of "true color".

Bartsch DU, Freeman WR, Lopez AM. Bartsch DU, et al. Arch Ophthalmol. 2002 May;120(5):675-6; author reply 676. Arch Ophthalmol. 2002. PMID: 12003634 No abstract available.

3

Retinal imaging with a low-cost micromachined membrane deformable mirror.

Bartsch DU, Zhu L, Sun PC, Fainman S, Freeman WR. Bartsch DU, et al. J Biomed Opt. 2002 Jul;7(3):451-6. doi: 10.1117/1.1483083. J Biomed Opt. 2002. PMID: 12175296 Free article.

4

Efficacy of Prinomastat) (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization.

Garcia C, Bartsch DU, Rivero ME, Hagedorn M, McDermott CD, Bergeron-Lynn G, Cheng L, Appelt K, Freeman WR. Garcia C, et al. Among authors: bartsch du. Curr Eye Res. 2002 Jan;24(1):33-8. doi: 10.1076/ceyr.24.1.33.5429. Curr Eye Res. 2002. PMID: 12187492

5

Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.

Rodanant N, Friberg TR, Cheng L, Aurora A, Bartsch D, Toyoguchi M, Corbin PS, El-Bradey MH, Freeman WR. Rodanant N, et al. Am J Ophthalmol. 2002 Oct;134(4):577-85. doi: 10.1016/s0002-9394(02)01691-4. Am J Ophthalmol. 2002. PMID: 12383815 Clinical Trial.

6

Oral fluorescein angiography in patients with choroidal neovascularization and macular degeneration.

Bartsch DU, Elmusharaf A, El-Bradey M, Freeman WR. Bartsch DU, et al. Ophthalmic Surg Lasers Imaging. 2003 Jan-Feb;34(1):17-24. Ophthalmic Surg Lasers Imaging. 2003. PMID: 12570000

7

Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.

Koh HJ, Bessho K, Cheng L, Bartsch DU, Jones TR, Bergeron-Lynn G, Freeman WR. Koh HJ, et al. Among authors: bartsch du. Invest Ophthalmol Vis Sci. 2004 Feb;45(2):635-40. doi: 10.1167/iovs.03-0735. Invest Ophthalmol Vis Sci. 2004. PMID: 14744908 Free PMC article.

8

Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization.

El Bradey M, Cheng L, Bartsch DU, Appelt K, Rodanant N, Bergeron-Lynn G, Freeman WR. El Bradey M, et al. Among authors: bartsch du. J Ocul Pharmacol Ther. 2004 Jun;20(3):217-36. doi: 10.1089/1080768041223657. J Ocul Pharmacol Ther. 2004. PMID: 15279727 Free PMC article.

9

The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinase, on a new animal model of epiretinal membrane.

El-Bradey MH, Cheng L, Bartsch DU, Niessman M, El-Musharaf A, Freeman WR. El-Bradey MH, et al. Among authors: bartsch du. Retina. 2004 Oct;24(5):783-9. doi: 10.1097/00006982-200410000-00016. Retina. 2004. PMID: 15492635

10

Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT.

Kozak I, Bartsch DU, Cheng L, Kosobucki BR, Freeman WR. Kozak I, et al. Among authors: bartsch du. Am J Ophthalmol. 2005 Feb;139(2):295-301. doi: 10.1016/j.ajo.2004.09.039. Am J Ophthalmol. 2005. PMID: 15733991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters